VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 20, 2007) - WEX Pharmaceuticals Inc. (“WEX” or the “Company”) (TSX:WXI) today announces that further to its news release dated August 16, 2007, the BC Securities Commission has granted the Company an order precluding management and other insiders from trading in the Company’s shares pending filing of the Company’s interim financial statements for the first fiscal quarter ended June 30, 2007 along with the related Management’s Discussion and Analysis.
